Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms

AIM: In the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF), aldosterone blockade with eplerenone decreased mortality and hospitalisation in patients with mild symptoms (New York Heart Association class II) and chronic systolic heart failure (HF). The pr...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Lee, Dawn, Wilson, Koo, Akehurst, Ron, Cowie, Martin R, Zannad, Faiez, Krum, Henry, van Veldhuisen, Dirk J, Vincent, John, Pitt, Bertram, McMurray, John J V
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2014
Teme:
Heart Failure and Cardiomyopathies
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4215293/
https://ncbi.nlm.nih.gov/pubmed/24993605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2014-305673
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items